 |
인쇄하기
취소
|
Yuyu to launch Uclid tablets
Yuyu Pharm received marketing approval from the Korean Food and Drug Administration (KFDA) for Uclid, a combination of ticlopidine HCl and ginkgo biloba extract.
Uclid will be marketed in June in 80 mg tablet strength.
It took 10 years to develop Uclid since the company initiated its study, according to a Yuyu official.
Uclid is effective in the treatment of cerebral apoplexy, myocardi...
Uclid will be marketed in June in 80 mg tablet strength.
It took 10 years to develop Uclid since the company initiated its study, according to a Yuyu official.
Uclid is effective in the treatment of cerebral apoplexy, myocardi...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.